ListarProducción científica por tema "Artritis reumatoide"
Mostrando ítems 1-1 de 1
-
Intravenous tocilizumab in the management of rheumatoid arthritis: Clinical practice findings from a 6-month international, multicentre, observational study in Central America and the Caribbean
(Revista Colombiana de Reumatología, 2020)Tocilizumab (TCZ), an interleukin-6 receptor-α inhibitor, is indicated in patients with moderate to severe rheumatoid arthritis with inadequate response to disease modifying drugs. ACT UP is a multinational project collecting ...